NO20070979L - Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet - Google Patents
Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighetInfo
- Publication number
- NO20070979L NO20070979L NO20070979A NO20070979A NO20070979L NO 20070979 L NO20070979 L NO 20070979L NO 20070979 A NO20070979 A NO 20070979A NO 20070979 A NO20070979 A NO 20070979A NO 20070979 L NO20070979 L NO 20070979L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- effective
- significant
- treatment
- effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60347904P | 2004-08-20 | 2004-08-20 | |
PCT/US2005/029371 WO2006023630A2 (fr) | 2004-08-20 | 2005-08-18 | Utilisation de composes diazaspiracycliques n-aryle dans le traitement de la toxicomanie |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070979L true NO20070979L (no) | 2007-03-19 |
Family
ID=35447974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070979A NO20070979L (no) | 2004-08-20 | 2007-02-21 | Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060058328A1 (fr) |
EP (1) | EP1784184A2 (fr) |
JP (1) | JP2008510711A (fr) |
KR (1) | KR20070043008A (fr) |
CN (1) | CN101022801A (fr) |
AU (1) | AU2005277410B2 (fr) |
BR (1) | BRPI0514509A (fr) |
CA (1) | CA2575461A1 (fr) |
IL (1) | IL180929A0 (fr) |
MX (1) | MX2007002045A (fr) |
NO (1) | NO20070979L (fr) |
NZ (1) | NZ552792A (fr) |
RU (1) | RU2387647C9 (fr) |
UA (1) | UA92327C2 (fr) |
WO (1) | WO2006023630A2 (fr) |
ZA (1) | ZA200701193B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
ATE359075T1 (de) * | 2002-12-20 | 2007-05-15 | Niconovum Ab | Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose |
EP1998748B1 (fr) | 2006-03-16 | 2015-01-14 | NicoNovum AB | Composition améliorée de tabac à priser |
US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
US8575167B2 (en) | 2007-02-06 | 2013-11-05 | Takeda Pharmaceutical Company Limited | Spiro compounds having stearoyl-CoA desaturase action |
RU2010133976A (ru) * | 2008-01-15 | 2012-02-27 | Таргасепт, Инк. (Us) | Получение и энантиомерное разделение 7-(3-пиридинил)-1,7-диазаспиро[4,4]нонана и новые солевые формы рацемата и энантиомеров |
CN102070640A (zh) * | 2009-11-24 | 2011-05-25 | 上海药明康德新药开发有限公司 | 一种1,7-二氮杂螺[4,5]壬烷及其衍生物的合成方法 |
CN102918021B (zh) | 2010-05-27 | 2015-02-11 | 塔加西普特公司 | 烟碱受体非竞争性拮抗剂 |
CN102267995A (zh) * | 2010-06-04 | 2011-12-07 | 艾琪康医药科技(上海)有限公司 | 一种制备二氮杂螺环化合物的方法 |
CN102516146B (zh) * | 2011-11-24 | 2013-10-02 | 爱斯特(成都)生物制药有限公司 | 5位为氮的四元氮杂螺环衍生物及其制备方法和用途 |
GB201416352D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
GB201416351D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
RU2635105C1 (ru) * | 2016-07-15 | 2017-11-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет" | Способ получения 4-арил-2,7,9-триазаспиро[4.5]декан-6,8,10-трионов |
BR112019001768A2 (pt) * | 2016-08-01 | 2019-06-11 | Aptinyx Inc | moduladores do receptor de spiro-lactamas nmda e usos dos mesmos |
TW202210472A (zh) | 2020-06-05 | 2022-03-16 | 美商奇奈特生物製藥公司 | 纖維母細胞生長因子受體激酶之抑制劑 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3282947A (en) * | 1962-05-17 | 1966-11-01 | Geschickter Fund Med Res | Unsymmetrically substituted 3, 9-diazaspiro(5, 5)undecane compounds |
US4922901A (en) * | 1988-09-08 | 1990-05-08 | R. J. Reynolds Tobacco Company | Drug delivery articles utilizing electrical energy |
AU6226494A (en) * | 1993-03-04 | 1994-09-26 | Pfizer Inc. | Spiroazacyclic derivatives as substance p antagonists |
US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
WO1997001556A1 (fr) * | 1995-06-29 | 1997-01-16 | Novo Nordisk A/S | Nouveaux composes azacycliques et azabicycliques substitues |
US5616716A (en) * | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
US5663356A (en) * | 1996-04-23 | 1997-09-02 | Ruecroft; Graham | Method for preparation of aryl substituted alefinic secondary amino compounds |
US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
DK0970957T3 (da) * | 1998-06-12 | 2001-12-03 | Hoffmann La Roche | Diaza-spiro[3.5]nonan-derivativer |
WO2001030780A2 (fr) * | 1999-10-27 | 2001-05-03 | Cor Therapeutics, Inc. | Composes spirocycliques pyridiles inhibiteurs de l'agregation plaquettaire dependant des fibrinogenes |
OA12245A (en) * | 2000-04-10 | 2003-11-10 | Pfizer Prod Inc | Benzoamide piperidine compounds as substance P antagonists. |
EA009789B1 (ru) * | 2002-07-05 | 2008-04-28 | Таргасепт, Инк. | N-арилдиазаспирациклические соединения и способы их получения и применения |
-
2005
- 2005-08-18 RU RU2007110020/04A patent/RU2387647C9/ru not_active IP Right Cessation
- 2005-08-18 MX MX2007002045A patent/MX2007002045A/es active IP Right Grant
- 2005-08-18 AU AU2005277410A patent/AU2005277410B2/en not_active Ceased
- 2005-08-18 CA CA002575461A patent/CA2575461A1/fr not_active Abandoned
- 2005-08-18 EP EP05786530A patent/EP1784184A2/fr not_active Withdrawn
- 2005-08-18 JP JP2007528005A patent/JP2008510711A/ja not_active Withdrawn
- 2005-08-18 NZ NZ552792A patent/NZ552792A/en not_active IP Right Cessation
- 2005-08-18 US US11/207,102 patent/US20060058328A1/en not_active Abandoned
- 2005-08-18 UA UAA200702904A patent/UA92327C2/ru unknown
- 2005-08-18 WO PCT/US2005/029371 patent/WO2006023630A2/fr active Application Filing
- 2005-08-18 CN CNA200580031767XA patent/CN101022801A/zh active Pending
- 2005-08-18 BR BRPI0514509-0A patent/BRPI0514509A/pt not_active IP Right Cessation
- 2005-08-18 KR KR1020077003860A patent/KR20070043008A/ko not_active Application Discontinuation
-
2007
- 2007-01-24 IL IL180929A patent/IL180929A0/en unknown
- 2007-02-09 ZA ZA200701193A patent/ZA200701193B/xx unknown
- 2007-02-21 NO NO20070979A patent/NO20070979L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ552792A (en) | 2009-12-24 |
IL180929A0 (en) | 2007-07-24 |
JP2008510711A (ja) | 2008-04-10 |
KR20070043008A (ko) | 2007-04-24 |
EP1784184A2 (fr) | 2007-05-16 |
US20060058328A1 (en) | 2006-03-16 |
MX2007002045A (es) | 2007-03-29 |
RU2007110020A (ru) | 2008-09-27 |
AU2005277410A1 (en) | 2006-03-02 |
CA2575461A1 (fr) | 2006-03-02 |
RU2387647C2 (ru) | 2010-04-27 |
RU2387647C9 (ru) | 2011-05-27 |
BRPI0514509A (pt) | 2008-06-10 |
AU2005277410B2 (en) | 2010-06-24 |
CN101022801A (zh) | 2007-08-22 |
WO2006023630A2 (fr) | 2006-03-02 |
WO2006023630A3 (fr) | 2006-05-04 |
UA92327C2 (ru) | 2010-10-25 |
ZA200701193B (en) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070979L (no) | Anvendelse av N-aryldiazaspirasykliske forbindelser i behandling av avhengighet | |
NO20050012L (no) | N-aryldiazaspiracykliske forbindelser og fremgangsmater for fremstilling og anvendelse derav | |
NO20050569L (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
JP2011500506A5 (fr) | ||
WO2002083109A1 (fr) | Traitement du diabete de type 2 a l'aide d'inhibiteurs de dipeptidylpeptidase iv | |
AU2002244860A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
MX2009012558A (es) | Combinaciones de farmacos para el tratamiento de distrofia muscular de duchenne. | |
IN2015DN01132A (fr) | ||
UY27627A1 (es) | Aza - arilpiperazinas | |
JP2007519649A5 (fr) | ||
CY1109370T1 (el) | Παραγωγα οξαδιαζολονης ως ppar δελτα αγωνιστες | |
TW200604193A (en) | Substituted oxazole-benzoisothiazole dioxide derivatives, process for their preparation and their use | |
MY142551A (en) | Substituted diaryl heterocycles, process for their preparation and their use as medicaments | |
JP2014528901A5 (fr) | ||
MX2007011009A (es) | Compuestos de piperidina 3,4,5-substituidos. | |
JP2019515908A5 (fr) | ||
JP2019520344A5 (fr) | ||
NO20054380L (no) | Arylsykloalkylderivater med forgrenede sidekjeder som PPAR-reseptormodulatorer, deres fremstilling og deres anvendelse som legemiddel | |
US20230250054A1 (en) | Selective histone deacetylase 6 inhibitors | |
BR0306798A (pt) | Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes. | |
PT1634595E (pt) | Derivados de n-fenilbenzamida como fármacos para o tratamento doença pulmonar obstativa crónica (dpoc) | |
EA201000739A1 (ru) | Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата | |
JP2006517562A5 (fr) | ||
MX2008015324A (es) | Derivados de pirrolidina utiles como inhibidores de bace. | |
MY137679A (en) | 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |